C5a was found to increase the release of IL-1β and IL-6 when added to Aβ-primed human monocytes in vitro [179] and C5aR1 antagonists have been found to reduce proinflammatory cytokines (IL-1β) in periodontal disease [180]. The gene discussed is IL1B; the disease is periodontal disorder.